![Austine Graff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Austine Graff first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Austine Graff via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Leeds | College/University | Doctorate Degree | |
Yale University | College/University | Corporate Officer/Principal | |
University of Virginia | College/University | Corporate Officer/Principal | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
LYELL IMMUNOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Appia Bio, Inc.
![]() Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member |
Statistics
International
United States | 8 |
United Kingdom | 2 |
Belgium | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 4 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Independent Dir/Board Member | 2 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Margo Roberts | 10 |
- Stock Market
- Insiders
- Austine Graff
- Company connections